Medicenna Therapeutics Corp.
MDNA.TO
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -19.73M | -19.68M | -19.40M | -18.88M | -11.42M |
Total Depreciation and Amortization | 25.40K | 13.20K | 5.80K | 2.80K | 2.80K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 8.12M | 7.52M | 7.27M | 6.27M | -659.20K |
Change in Net Operating Assets | -364.80K | -222.80K | 953.90K | 547.70K | 1.91M |
Cash from Operations | -11.95M | -12.37M | -11.18M | -12.06M | -10.16M |
Capital Expenditure | -24.20K | -24.20K | -22.70K | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -24.20K | -24.20K | -22.70K | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 23.81M | 21.90M | 20.90M | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -189.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -300.00K | -300.00K | -- | -- | -- |
Cash from Financing | 17.15M | 15.79M | 15.27M | -- | -139.70K |
Foreign Exchange rate Adjustments | 784.70K | -13.40K | 197.00K | -264.60K | -372.70K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 5.96M | 3.38M | 4.27M | -12.32M | -10.67M |